Employee Resources

This year's Annual Report spotlights the work of the new Duke Center for Brain and Spine Metastasis at DCI as well as a Duke-Durham stomach cancer prevention partnership. 

Medical oncologist Edwin P. Alyea, III, MD, formerly with Dana-Farber Cancer Institute, has been named chief medical officer (CMO) for Duke Cancer Institute.

The School of Medicine is launching a new live storytelling series in 2020 to showcase the diverse stories of the people across the Duke Health community.

Updated genetic screening guidelines published by NCCN feature emerging evidence on personalized medicine.

ICYMI the AACI's Physician Clinical Leadership Initiative (PCLI) presented a two-part webinar series on hereditary cancer programs and cancer risk assessment.

Jennifer Kennedy-Stovall, formerly with the University of Texas, MD Anderson Cancer Center, has been named director of DCI Patient Access.

Duke Hematologic Malignancies & Cellular Therapy will host its second annual benefit Cornhole Games on Thursday, Oct. 3.

For a second year, Duke Cancer Institute will present its annual DCI Superstar Awards in person at cancer centers in Durham and Wake County.

Throughout September, Myrna Halpern Jewelry will donate 20 percent of all online sales to Duke Cancer Institute. Halpern is a two-time cancer survivor.